DrugDev
About DrugDev
DrugDevs unified platform enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for global site payments, site identification and activation, workflow optimization, learning management, and site and patient engagement, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev technology at drugdev.com.
DrugDev Continues Robust Growth in Europe, Attracts Veteran Pharmaceutical Industry Senior Executive George Masoura as Vice President of Business Development
LONDON UK and Philadelphia PA - Adoption of DrugDev Spark™, the worldís first unified clinical operations suite, continues to escalate worldwide with strong demand in Europe and ROW for proven solutions including site selection, activation, eConsent, LMS and global site payments. To support this rapid growth, George Masoura has joined the company as Vice President,...
DrugDev Hosts New Educational Webinar on Overcoming the Challenges of Rare Disease Clinical Trials
King of Prussia, PA - Over 8,000 recognized rare diseases afflict an estimated 350 million people worldwide - 50% of them children. In a new educational webinar on March 7 DrugDev will gather international experts to share challenges and provide insight and best practices to pharma professionals working in this especially difficult area. Webinar: Overcoming...
DrugDev Spark™ Introduced as the First Comprehensive Unified Suite of Proven Solutions for Clinical Operations
King of Prussia, PA - For years, the pharmaceutical industry has demanded a unified technology solution that provides everything study teams and sites need to run an efficient clinical trial in one place. Today at the SCOPE Summit for Clinical Operations Executives, DrugDev unveiled DrugDev Spark™, the industryís first comprehensive unified suite of proven technology...
DrugDev Launches CRO Preferred Partner Program with Charter Member INC Research
KING OF PRUSSIA, PA - June 28, 2016 - For years, DrugDev technology has been used directly by leading pharmaceutical companies to improve how their clinical trials are run. In order to advance collaboration and standardization that drive benefits throughout the industry and enable companies to do more trials, the company has launched its CRO...
DrugDev to Showcase Award-Winning Clinical Trial Operations Technology at the DIA 52nd Annual Meeting
KING OF PRUSSIA, PA - Pharma industry professionals at the DIA 52nd Annual Meeting in Philadelphia, June 26-30 will learn about the quantifiable benefits of using modern technology to do more clinical trials as DrugDev executives discuss and demonstrate its award-winning technology in Booth #1842. Visit DrugDev at exhibit booth #1842 to learn about the...
DrugDev Hosts New Educational Webinar: Conquer the Challenges of Investigator Payments in Global Clinical Trials
KING OF PRUSSIA, PA - May 19, 2016 - DrugDev will host an educational webinar to give pharmaceutical industry financial professionals dependable advice on how to successfully navigate the growing intricacies of global Investigator payments. Webinar: Conquer the Challenges of Investigator Payments in Global Clinical Trials Date: May 26, 2016 Time: 10:00-11:00 am ET CLICK...
DrugDev President and CEO Ibraheem (Ibs) Mahmood Named to The Medicine Maker International Power 100, Honored as Tech Disruptor by the Philadelphia Business Journal
KING OF PRUSSIA, PA - May 6, 2016 - DrugDev President and CEO Ibraheem 'Ibs' Mahmood continues to earn accolades for his success in changing the way the pharmaceutical industry conducts clinical trials. This month Ibs was named No. 20 on The Medicine Maker Power 100 list of the worldís most influential people in pharma,...
DrugDev Launches Clinical Site Activation SaaS Technology as Key Part of Its Unified Platform to Reduce the Time of Startup from Months to Weeks
KING OF PRUSSIA, PA - February 22, 2016 - DrugDev continues to add innovative technology features to its award-winning platform for clinical trial optimization with its new site activation module, which can reduce startup time from months to weeks. Based upon years of proven best practices of helping leading sponsors and CROs shave months off...
1170 Devon Park Drive Suite 300, Wayne, PA 19087
+1 888 650 1860
